Reinsurance Group of America (NYSE: RGA), which had previously been awarded a “buy” rating by Bloomberg research analysts, was given a rating of “hold” in a research note that was distributed to investors on Saturday. This rating contrasts the previous rating of “buy” that had been assigned. In addition to this, RGA has been the subject of a significant number of additional scientific studies and investigations. Barclays increased their price objective on Reinsurance Group of America from $120.00 to $135.00 in a research report made available to the public on Tuesday, August 16. The “equal weight” rating was another one of the firm’s evaluations of the enterprise.
In a research note made public on July 11, JPMorgan Chase & Co. indicated that it had increased its price objective for Reinsurance Group of America from $131.00 to $136.00. The note was made public by JPMorgan Chase & Co. Morgan Stanley increased their price objective on Reinsurance Group of America from $135.00 to $140.00 in a research report made available to the public on Wednesday, August 17. The “equal weight” rating was another one of the firm’s evaluations of the enterprise. A research study made available to the public on Thursday, June 2, by Credit Suisse Group stated that the rating of Reinsurance Group of America had been raised. The previous rating of “underperform” was changed to “neutral.” In addition, the company has lifted its price target for the stock from $80.00 to $122.00.
In a research report published on May 27, Piper Sandler upgraded Reinsurance Group of America from “underweight” to “overweight” in a research report. Piper Sandler did not restrict her alterations to this one facet of the story. Seven analysts have shared their thoughts on the stock, and of those seven, four have suggested buying the firm, five of them have suggested holding on to the stock, and two of them have suggested selling the stock. According to Bloomberg, the average rating for the company is “Hold,” and the overall consensus price goal for the company is reported to be $129.27. NYSE RGA began trading at $127.70 on Friday.
Reinsurance Group of America reached an all-time high of $132.12 per share after falling to a 52-week low of $94.32 per share during the same period. The average price of the company’s stock over the previous 50 days is $119.70, and the average price for the previous 200 days is $115.33. The quick ratio, the current ratio, and the current ratio are all 0.12 at the same moment, but the debt to equity ratio is 0.62. The price-to-earnings ratio for the company is 32.17, and the beta value for the stock is 1.00. The market value of the company is $8.55 billion. The earnings report for Reinsurance Group of America (NYSE: RGA) was made available to the general public on August 4.
The insurance provider reported a profit of $5.78 per share for the previous quarter, which was $3.08 higher than the median expectation of $2.70 per share. The Reinsurance Group of America had a return on equity of 3.02 percent, and the company’s net margin reached 1.66 percent. The corporation made $4.00 per share at the same time the year before. The current fiscal year is expected to result in profits of $12.04 per share for Reinsurance Group of America. These projections are based on the findings of market experts.
According to information about Reinsurance Group of America, Chief Financial Officer Todd C. Larson sold 2,729 shares on Friday, August 12. This transaction was mentioned in earlier news regarding the company. The entire value of the stock sold was $357,908.35, and it was sold for $131.15 per share, on average. The deal has resulted in the chief financial officer gaining direct ownership of 36,921 shares. These shares are currently trading at a price corresponding to a market value of $4,842,189.15.
The disclosure of the transaction was made public by the Securities and Exchange Commission in the form of a filing, which may be obtained by following the link provided here: Corporate insiders hold 1.55 percent of the total number of shares in the corporation. Recent months have seen several modifications implemented by various institutional investors, including hedge funds and other types, regarding how they invest in RGA.
During the fiscal quarter that ended on December 31, Cambridge Stake Research Advisors, Inc. added a new investment in the Reinsurance Group of America of 211,000 dollars to its portfolio. Envestnet Asset Management Inc. increased the amount of Reinsurance Group of America stock owned by 4.8% during the fourth and final quarter of 2018.
The insurance provider now has 82,441 shares of the stock held by Envestnet Asset Management Inc. following the acquisition of an additional 3,746 shares during the most recent fiscal quarter. These 82,441 shares are worth a total of $9,026,000 when combined as a whole. The fourth quarter of 2018 saw SG Americas Securities LLC increase its stake in Reinsurance Group of America by 115.5% compared to the previous quarter. SG Americas Securities LLC now has 6,044 shares of the insurance provider’s firm after purchasing an additional 3,239 shares over the preceding quarter. The company’s shares are currently valued at a combined total of $622,000.
Following the acquisition of an additional 1,366 shares during the most recent quarter, ProShare Advisors LLC now owns 11,929 shares of the insurance provider’s stock, which is $1,306,000. In the fourth and final quarter of 2018, First Trust Advisors LP saw a 56.9% rise in the proportion of Reinsurance Group of America stock it owned. It is by no means the least important of these developments. First Trust Advisors LP now owns 172,692 shares of the insurance provider’s stock, which has a market value of $18,908,000 after purchasing an additional 62,640 shares during the most recent quarter.
This brings the total number of shares that the firm has acquired to a total of 172,692. Institutional investors collectively own the company’s shares to 96.37%. The company, known as Reinsurance Group of America, Inc., is in the business of providing reinsurance to clients. Both private and public customers can take advantage of the company’s asset-intensive and financial reinsurance products.
It also sells products like term life, credit life, universal life, whole life, group life and health insurance, joint and last survivor insurance, critical illness insurance, disability insurance, and longevity insurance.